DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$0.64
+0.02 (+2.40%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+544.8% upside
Low Target
$2.96
Average Target
$4.12
High Target
$5.49
Current Price
$0.64
Current
$0.64
$0.64
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Scenario Analysis
Bear Case
$2.96
363.2%
Low target
Base Case
$4.12
+544.8%
Avg target
Bull Case
$5.49
+759.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.78
-83.1% from high
52-Week Low
$0.61
+4.8% from low
Target vs 52W High
$4.12
+9.0% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.27
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals